Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Histogen Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
      Biotech

      Histogen Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

      July 25, 2022
      Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
      Biotech

      Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      July 25, 2022
      Vaxcyte Completes Enrollment of Phase 2 Portion of Phase 1/2 Clinical Proof-of-Concept Study Evaluating Safety, Tolerability and Immunogenicity of VAX-24 in Adults
      Biotech

      Vaxcyte Completes Enrollment of Phase 2 Portion of Phase 1/2 Clinical Proof-of-Concept Study Evaluating Safety, Tolerability and Immunogenicity of VAX-24 in Adults

      July 25, 2022
      The GBT Foundation Awards $250,000 in ACE Grants to Support Sickle Cell Disease Community-Based Organizations
      Biotech

      The GBT Foundation Awards $250,000 in ACE Grants to Support Sickle Cell Disease Community-Based Organizations

      July 25, 2022
      Royalty Pharma Agrees to Acquire Royalty Interest in TRELEGY ELLIPTA From Theravance and Innoviva for $1.31 Billion and Potential Milestones of $300 Million
      Biotech

      Royalty Pharma Agrees to Acquire Royalty Interest in TRELEGY ELLIPTA From Theravance and Innoviva for $1.31 Billion and Potential Milestones of $300 Million

      July 25, 2022
      Agios to Webcast Conference Call of Second Quarter 2022 Financial Results on August 4, 2022
      Biotech

      Agios to Webcast Conference Call of Second Quarter 2022 Financial Results on August 4, 2022

      July 25, 2022
      Cocrystal Pharma Reports CC-42344 Pharmacokinetic Data in Influenza A Once-Daily Dosing
      Biotech

      Cocrystal Pharma Reports CC-42344 Pharmacokinetic Data in Influenza A Once-Daily Dosing

      July 25, 2022
      GBT Initiates Expanded Access Program for Voxelotor in Patients With Sickle Cell Disease in Brazil
      Biotech

      GBT Initiates Expanded Access Program for Voxelotor in Patients With Sickle Cell Disease in Brazil

      July 25, 2022
      SpringWorks Therapeutics Appoints Carlos Albán to its Board of Directors
      Biotech

      SpringWorks Therapeutics Appoints Carlos Albán to its Board of Directors

      July 25, 2022
      BioCryst to Present at Upcoming Investor Conference
      Biotech

      BioCryst to Present at Upcoming Investor Conference

      July 25, 2022
      « 1 … 124 125 126 127 128 … 133 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026